反応式
[S:1]1[CH:5]=[CH:4][N:3]=[CH:2]1.[Li]CCCC.Cl[C:12]1[C:13]2[N:21]=[N:20][N:19]([CH2:22][C:23]3[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=3[F:29])[C:14]=2[N:15]=[C:16]([NH2:18])[N:17]=1>C1COCC1.[Cl-].[Cl-].[Zn+2].C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[F:29][C:24]1[CH:25]=[CH:26][CH:27]=[CH:28][C:23]=1[CH2:22][N:19]1[C:14]2[N:15]=[C:16]([NH2:18])[N:17]=[C:12]([C:2]3[S:1][CH:5]=[CH:4][N:3]=3)[C:13]=2[N:21]=[N:20]1参加物
7
反応物 3
生成物 1
試薬・触媒・溶媒 3
実験手順
A stirred solution of thiazole (0.10 mL, 1.43 mmol) in dry THF (5 mL) at −78° C., under argon was treated with n-BuLi (0.9 mL, 1.6-M in hexanes, 1.43 mmol), stirred for 30 min, treated with a solution of ZnCl2 (1.8 mL, 1-M in Et2O, 1.80 mmol) and allowed to warm gradually to room temperature. The mixture was treated with 7-chloro-3-(2-fluorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine (200 mg, 0.714 mmol) and Pd(PPh3)4 (50 mg), refluxed for 2 h and partitioned between saturated NH4Cl (20 mL) and EtOAc (20 mL). The organic phase was dried (MgSO4), concentrated in vacuo and purified by chromatography [SiO2; iso-hexane:EtOAc (1:1)] to give the title compound (70 mg, 30%) as a cream solid.
後処理
- temperaturerefluxed for 2 h
- custompartitioned between saturated NH4Cl (20 mL) and EtOAc (20 mL)
- dry with materialThe organic phase was dried (MgSO4)
- concentrationconcentrated in vacuo
- custompurified by chromatography [SiO2; iso-hexane:EtOAc (1:1)]
出典と根拠
- ORDレコード
- ord-243f4dc29ae14c6b8a6ea532c4b1849b
- 出典データセット
- uspto-grants-2009_09
- 特許番号
- US07589097B2
関連ノート
読み込み中…